PAEDIATRIC TUBERCULOSIS MAY STILL BE UNDER DIAGNOSED AND UNDER TREATED

Slides:



Advertisements
Similar presentations
TB 101 “Basic Facts on Tuberculosis”
Advertisements

` COMPARATIVE ACCURACY OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST AND SPUTUM MICROSCOPY FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN HIV POSITIVE.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Inaugural Conference of the African Health Economics and Policy Association (AfHEA) Accra - Ghana, 10th - 12th March 2009 Patent medicines vendors a resource.
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
Factors Associated with Interruption of Treatment Among Pulmonary Tuberculosis Patients in Plateau State, Nigeria, 2011 Luka M. Ibrahim 1, P. Nguku 1,
Introduction Hypothesis Conclusions Specific Aims In-home Intervention Improves Outcomes of Tuberculosis Patients in Zimbabwe, Africa Olga Kishek, Tess.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2013
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2014
Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
DEPARTMENT OF HEALTH DOTS Program for TB (Tuberculosis Directly Observed Short-course)
Tuberculosis Research of INA-RESPOND on Drug-resistant
Progress of the Singapore TB Elimination Programme (STEP)
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Module 2 TB Disease Transmission & Prevention. Pulmonary Tuberculosis Extra -Pulmonary TB an infectious disease caused by a microorganism called Mycobacterium.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 8.
Sunil Kumar, B.K.Kapoor, Urvinderpal Singh, Vidhu Mittal Department of Pulmonary Medicine, GMC,Patiala PRESENTATION OF PULMONARY TUBERCULOSIS IN ELDERLY.
The 16 th International Conference on AIDS & STIs in Africa, Addis Ababa Trends in HIV Seroprevalence among clients with newly diagnosed tuberculosis in.
Roundtable. Detection and treatment of TB Andrew Black.
Using implementation science to improve child household contact screening for tuberculosis in Eldoret, Kenya: Overview and lessons learned Daria Szkwarko,
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
Instructional Objectives:
Monitoring and Evaluation: A Review of Terms
CASES OF PLEURAL EFFUSION (n=56)
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
Daniel Meressa, M.D. Global Health Committee St. Peter’s Hospital
14th European AIDS Conference
World Tuberculosis Day 2013
World Tuberculosis Day 2014
Jayesh J Rana1, Prakash B Patel2, A B Pawar3, R K Bansal4
Daffodil International University (DIU), Dhaka Bangladesh
R Nagar 1, Debashish Kundu2, S Chandra2 , A Khanna1
Dr Dawood Quiz questions.
University of Witwatersrand, Johannesburg, South Africa
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
Figure 3. The majority of patients have obstructive lung function
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
PROGRESS IN GLOBAL TB CONTROL
اهمیت سل در چیست؟ حدود یک سوم جمعیت جهان(2 میلیارد نفر)با میکروب سل آلوده شده اند سالانه 9 میلیون نفر به سل فعال مبتلا می شوند هر ساله 1/5 تا 2 میلیون.
Presentation 10 Analysing results and defining cases
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
بسم الله الرحمن الرحيم.
World Tuberculosis Day 2014
World Tuberculosis Day 2016
Background 1  § About 1/3 of world population infected with Tuberculosis (TB) § 25% of all avoidable deaths in developing countries due to TB.
2Public Health Unit. Komfo Anokye Teaching Hospital
Community Pharmacists Monitoring of Pulmonary Tuberculosis Outpatients (Preliminary Study)
Indian Scenario HIV Situation TB Situation
Buhera District.
TB epidemiological situation in Kyrgyzstan
From TB control to integrated respiratory disease control
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
Cheng shiming National TB Center in China May,3, 2004
Anti Tuberculosis Norah A A AL KHATHLAN MD 4/18/2019 Failure or MDR_TB.
Surveillance of Tuberculosis
TB epidemiology in Bulgaria
Epidemiology of Tuberculosis in Hong Kong
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Collaborative TB/HIV activities in European Region
Monitoring and Evaluation: A Review of Terms
Community Pharmacists Monitoring of Pulmonary Tuberculosis Outpatients (Preliminary Study)
TB Screening and Differentiated Service Delivery: State of the Art
The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection  O. Opota, J. Mazza-Stalder,
Abstract Problem Statement: Armenia received anti-TB drugs from the Global Drug Facility to treat patients in the civil sector in January 2003, whereas.
Emilio Valverde, The Aurum Institute
Presentation transcript:

PAEDIATRIC TUBERCULOSIS MAY STILL BE UNDER DIAGNOSED AND UNDER TREATED 1Garba BI, 2Muhammad AS, 3Yusuf I, 4Ibrahim TM, 1Ahmad MM, 1Yusuf T, 5Onazi SO 1Department of Paediatrics, UDUTH, Sokoto, 2Department of Medicine, UDUTH , Sokoto , 3Department of Paediatrics, ASYBSH, Gusau, 4DOTS clinic, ASYBSH, Gusau; 5Federal Medical Centre, Gusau Introduction Tuberculosis (TB) is a chronic infectious disease that is preventable, treatable and curable; yet still a major cause of childhood morbidity and mortality. In order to decrease transmission of the disease, effective identification, diagnosis and treatment of infectious TB patients is required. A proven strategy to ensure patients’ adherence to anti-tuberculous medication is the use of Directly Observed Treatment Short course (DOTS) therapy. Evidence has suggested that TB prevalence and mortality are under-estimated in many high burden countries including Nigeria. DOTS is associated with significant improved treatment outcome with overall reduction in morbidity and development of multidrug resistant TB. Methods To determine the pattern and outcome of childhood tuberculosis managed at the DOTS clinic of Ahmad Sani Yariman Bakura Specialist Hospital (ASYBSH) Gusau, Zamfara State. Results 415 patients managed, 76(18.3%) were children; males were 30(39.5.2%), with a M: F ratio of 1:1.5. Mean±SD age was 8.89±5.38 years, with 29(38.2%) being under fives. 58(76.3%) had pulmonary TB, more females had PTB than males, which was not significant (χ2=1.350, p=0.245). Seventy five (98.7) were new cases, 1(1.3%) had HIV TB co infection. Acid fast bacilli were positive in 12(15.8%) while Gene Xpert MTB/RIF sensitivity was detected in 7(9.2%). Fifty one (67.1%) completed treatment, 12(15.8%) were cured, 9(11.8%) were transferred out, 3(3.9%) died, while 1(1.3%) was lost to follow up; with successful outcome of 82.9%. Methodology Retrospective study over a 30 months period (1st January 2015 to 30th June 2017). The clinic serves both children and adults. All children (<18 years) treated for tuberculosis over the study period were included. Relevant information from the register were retrieved and analysed accordingly. Treatment outcomes were assessed according to WHO and NTLCP guidelines. “Cured’’ and “treatment completed’’ outcomes were classified as treatment successful. Discussion Under fives were mostly affected, similar to findings in many studies (TB contributes to under five morbidity, this age group are prone to infections). Majority had PTB, similar to reports from other studies. This maybe because TB cases are primarily pulmonary and is easier to diagnose than extra pulmonary that requires high index of suspicion. The AFB detection rate was low, due to rarity of smear positive TB in children and difficulty to get sputum/gastric samples from children. Reason for the low HIV TB co infection could be attributable to the fact that Zamfara State has the lowest HIV seroprevalence in the country with 0.9%. Conclusion Treatment outcome using DOTS strategy was good, with a success rate close to 85% of WHO benchmark. However, as compared to the adult cases, the proportion of childhood TB appears low which may be attributable to under diagnosis and under treatment in our centre. bgilah@yahoo.com